Prostaglandin analogues and phosphodiesterase inhibitors, either alone or as add-on therapy, are effective treatments for vitiligo repigmentation.

Most patients with alopecia areata who had hair regrowth with baricitinib and discontinued maintenance therapy experienced a relapse of hair loss.

From 1990 to 2021, the burden of AMR decreased for those younger than 5 years and increased for those older than 70 years.

Long COVID is common among veterans in the Airborne Hazards and Open Burn Pit Registry; however, the risk is not augmented by deployment exposures.

Policy interventions to mitigate heat-related illness are needed based on the relationship between high HVI and severe stroke.

The FDA has accepted for filing the NDA for delgocitinib cream as a treatment for moderate to severe chronic hand eczema in adults.

High levels of well-being may protect against the risks for cardiovascular diseases, according to study findings.

Patients with PsA who received bimekizumab demonstrated sustained improvements in clinical outcomes for up to 52 weeks, regardless of concomitant MTX use.

The risk for hidradenitis suppurativa development was reduced among adults who quit smoking and maintained a smoke-free status.

Ingestion of erythritol, but not glucose, is associated with increased platelet reactivity and potential risk for thrombosis in healthy patients.

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx (bimekizumab-bkzx) to include 3 new indications.

The employment of telemedicine in the neurologic space may be valid for initial consultation, depending on the clinical scenario.